(Q33642616)

28 July 2017

title

Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway (English)

1 reference

28 July 2017

1 reference

Ping Li

1

1 reference

28 July 2017

Rei Shibata

2

1 reference

28 July 2017

Sonomi Maruyama

3

1 reference

28 July 2017

Megumi Kondo

4

1 reference

28 July 2017

Koji Ohashi

5

1 reference

28 July 2017

Noriyuki Ouchi

6

1 reference

28 July 2017

Toyoaki Murohara

7

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20663986

11 June 2024

publication date

27 July 2010

1 reference

full work available at URL

28 July 2017

http://intl-ajpendo.physiology.org/cgi/content/abstract/299/4/E560

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663986

https://www.physiology.org/doi/pdf/10.1152/ajpendo.00284.2010

11 June 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

American Journal of Physiology - Endocrinology and Metabolism

11 June 2024

published in

1 reference

28 July 2017

volume

299

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

E560-6

1 reference

Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin and inflammatory markers in peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Fenofibrate enhances neovascularization in a murine ischemic hindlimb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

The role of AMP-activated protein kinase in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00284.2010

Effect of diabetes mellitus on formation of coronary collateral vessels

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries

11 June 2024

2

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

AMP-activated protein kinase phosphorylation of endothelial NO synthase

11 June 2024

8

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men

11 June 2024

31

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

Biochimica et Biophysica Acta

11 June 2024

36

1736

51

Shimura M

2005

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

Obesity is associated with impaired coronary collateral vessel development

11 June 2024

40

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00284.2010

11 June 2024

Identifiers

1 reference

28 July 2017

1 reference